Birdwatch Note
2024-10-04 03:16:03 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Health authorities, including the NCI & the FDA, have stated that there is no scientific evidence to support the claim that fenbendazole can cure cancer in humans. Anecdotal reports & preliminary studies are not sufficient to establish its efficacy & safety in humans. https://www.simcoenaturopathic.ca/post/fenbendazole-is-it-safe-in-those-with-cancer https://www.politifact.com/factchecks/2023/feb/20/facebook-posts/no-proof-dog-deworming-drug-fenbendazole-can-cure/ https://factcheck.afp.com/doc.afp.com.33DM73U https://fullfact.org/health/fenbendazole-no-evidence-cancer-cure/ https://healthfeedback.org/claimreview/lack-clinical-evidence-dog-dewormer-fenbendazole-cures-cancer/
Written by 87862316201459CCE48B6F17413B86E3A1ADA24CD99D30D6D7BE90164C8A678A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1841929008285409627
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1842040960269557911
- noteId - 1842040960269557911
- participantId -
- noteAuthorParticipantId - 87862316201459CCE48B6F17413B86E3A1ADA24CD99D30D6D7BE90164C8A678A Participant Details
- createdAtMillis - 1728011763051
- tweetId - 1841929008285409627
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Health authorities, including the NCI & the FDA, have stated that there is no scientific evidence to support the claim that fenbendazole can cure cancer in humans. Anecdotal reports & preliminary studies are not sufficient to establish its efficacy & safety in humans. https://www.simcoenaturopathic.ca/post/fenbendazole-is-it-safe-in-those-with-cancer https://www.politifact.com/factchecks/2023/feb/20/facebook-posts/no-proof-dog-deworming-drug-fenbendazole-can-cure/ https://factcheck.afp.com/doc.afp.com.33DM73U https://fullfact.org/health/fenbendazole-no-evidence-cancer-cure/ https://healthfeedback.org/claimreview/lack-clinical-evidence-dog-dewormer-fenbendazole-cures-cancer/
Note Ratings
| rated at | rated by | |
| 2024-10-04 17:03:20 -0500 | Rating Details | |
| 2024-10-04 17:03:08 -0500 | Rating Details | |
| 2024-10-04 14:56:58 -0500 | Rating Details | |
| 2024-10-04 13:57:33 -0500 | Rating Details | |
| 2024-10-04 13:27:56 -0500 | Rating Details | |
| 2024-10-04 13:14:22 -0500 | Rating Details | |
| 2024-10-04 12:46:17 -0500 | Rating Details | |
| 2024-10-04 12:44:09 -0500 | Rating Details | |
| 2024-10-04 12:38:50 -0500 | Rating Details | |
| 2024-10-04 12:38:23 -0500 | Rating Details | |
| 2024-10-04 12:23:26 -0500 | Rating Details | |
| 2024-10-04 12:20:21 -0500 | Rating Details | |
| 2024-10-04 12:04:34 -0500 | Rating Details | |
| 2024-10-04 11:08:30 -0500 | Rating Details | |
| 2024-10-04 10:39:33 -0500 | Rating Details | |
| 2024-10-04 10:32:12 -0500 | Rating Details | |
| 2024-10-04 10:28:17 -0500 | Rating Details | |
| 2024-10-04 10:13:32 -0500 | Rating Details | |
| 2024-10-04 09:42:23 -0500 | Rating Details | |
| 2024-10-04 09:30:20 -0500 | Rating Details | |
| 2024-10-04 09:29:25 -0500 | Rating Details | |
| 2024-10-04 09:25:20 -0500 | Rating Details | |
| 2024-10-04 09:15:47 -0500 | Rating Details | |
| 2024-10-04 09:00:30 -0500 | Rating Details | |
| 2024-10-04 08:18:09 -0500 | Rating Details | |
| 2024-10-04 08:04:40 -0500 | Rating Details | |
| 2024-10-04 08:01:03 -0500 | Rating Details | |
| 2024-10-04 07:57:38 -0500 | Rating Details | |
| 2024-10-04 07:47:52 -0500 | Rating Details | |
| 2024-10-04 07:11:40 -0500 | Rating Details | |
| 2024-10-04 06:54:11 -0500 | Rating Details | |
| 2024-10-04 06:52:11 -0500 | Rating Details | |
| 2024-10-04 06:34:41 -0500 | Rating Details | |
| 2024-10-04 06:30:19 -0500 | Rating Details | |
| 2024-10-04 06:30:03 -0500 | Rating Details | |
| 2024-10-04 06:27:03 -0500 | Rating Details | |
| 2024-10-04 06:18:15 -0500 | Rating Details | |
| 2024-10-04 06:08:35 -0500 | Rating Details | |
| 2024-10-04 04:09:33 -0500 | Rating Details | |
| 2024-10-04 04:06:57 -0500 | Rating Details | |
| 2024-10-04 04:00:35 -0500 | Rating Details | |
| 2024-10-04 02:57:11 -0500 | Rating Details | |
| 2024-10-04 02:49:16 -0500 | Rating Details | |
| 2024-10-04 02:42:19 -0500 | Rating Details | |
| 2024-10-04 02:04:06 -0500 | Rating Details | |
| 2024-10-04 02:00:06 -0500 | Rating Details | |
| 2024-10-04 01:55:33 -0500 | Rating Details | |
| 2024-10-04 01:00:57 -0500 | Rating Details | |
| 2024-10-03 23:29:23 -0500 | Rating Details | |
| 2024-10-03 23:16:52 -0500 | Rating Details | |
| 2024-10-03 22:52:15 -0500 | Rating Details | |
| 2024-10-03 22:31:17 -0500 | Rating Details | |
| 2024-10-07 08:45:40 -0500 | Rating Details | |
| 2024-10-06 16:24:39 -0500 | Rating Details | |
| 2024-10-04 14:00:08 -0500 | Rating Details | |
| 2024-10-04 11:24:23 -0500 | Rating Details | |
| 2024-10-04 08:46:40 -0500 | Rating Details | |
| 2024-10-04 08:30:04 -0500 | Rating Details | |
| 2024-10-04 07:51:47 -0500 | Rating Details | |
| 2024-10-04 07:38:58 -0500 | Rating Details | |
| 2024-10-04 04:49:27 -0500 | Rating Details | |
| 2024-10-04 03:57:29 -0500 | Rating Details | |
| 2024-10-04 00:25:29 -0500 | Rating Details | |
| 2024-10-03 22:25:31 -0500 | Rating Details | |
| 2024-10-04 23:34:35 -0500 | Rating Details | |
| 2024-10-04 15:49:09 -0500 | Rating Details | |
| 2024-10-04 13:37:55 -0500 | Rating Details | |
| 2024-10-04 13:34:18 -0500 | Rating Details | |
| 2024-10-04 11:42:02 -0500 | Rating Details | |
| 2024-10-04 10:43:36 -0500 | Rating Details | |
| 2024-10-04 10:17:37 -0500 | Rating Details | |
| 2024-10-04 09:33:16 -0500 | Rating Details | |
| 2024-10-04 09:10:19 -0500 | Rating Details | |
| 2024-10-04 08:41:34 -0500 | Rating Details | |
| 2024-10-04 08:02:20 -0500 | Rating Details | |
| 2024-10-04 07:41:17 -0500 | Rating Details | |
| 2024-10-04 07:32:32 -0500 | Rating Details | |
| 2024-10-04 07:02:35 -0500 | Rating Details | |
| 2024-10-04 06:22:15 -0500 | Rating Details | |
| 2024-10-04 04:09:41 -0500 | Rating Details | |
| 2024-10-04 01:19:57 -0500 | Rating Details | |
| 2024-10-05 06:38:55 -0500 | Rating Details | |
| 2024-10-04 21:10:16 -0500 | Rating Details | |
| 2024-10-04 12:38:35 -0500 | Rating Details | |
| 2024-10-04 12:29:41 -0500 | Rating Details | |
| 2024-10-04 12:14:43 -0500 | Rating Details | |
| 2024-10-04 11:14:15 -0500 | Rating Details | |
| 2024-10-04 10:05:22 -0500 | Rating Details | |
| 2024-10-04 09:29:23 -0500 | Rating Details | |
| 2024-10-04 07:01:57 -0500 | Rating Details | |
| 2024-10-04 06:02:12 -0500 | Rating Details | |
| 2024-10-04 04:12:45 -0500 | Rating Details | |
| 2024-10-04 03:50:08 -0500 | Rating Details | |
| 2024-10-04 01:14:01 -0500 | Rating Details | |
| 2024-10-04 00:40:13 -0500 | Rating Details | |
| 2024-10-04 00:14:58 -0500 | Rating Details | |
| 2024-10-03 22:24:43 -0500 | Rating Details |